カテゴリ： 世界, 医療/バイオ, Market Monitor Global

がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療

■ 英語タイトル：Cancer Drug Therapy Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8387）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8387
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のがん薬物治療市場規模と予測を収録しています。・世界のがん薬物治療市場：売上、2018年-2023年、2024年-2029年
・世界のがん薬物治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のがん薬物治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標的治療」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

がん薬物治療のグローバル主要企業は、Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、がん薬物治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のがん薬物治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：タイプ別市場シェア、2022年
・標的治療、化学治療、免疫治療

世界のがん薬物治療市場：用途別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：用途別市場シェア、2022年
・血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫治療（IL-2）

世界のがん薬物治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるがん薬物治療のグローバル売上、2018年-2023年
・主要企業におけるがん薬物治療のグローバル売上シェア、2022年
・主要企業におけるがん薬物治療のグローバル販売量、2018年-2023年
・主要企業におけるがん薬物治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labs

*************************************************************

・調査・分析レポートの概要
がん薬物治療市場の定義
市場セグメント
世界のがん薬物治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のがん薬物治療市場規模
世界のがん薬物治療市場規模：2022年 VS 2029年
世界のがん薬物治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのがん薬物治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のがん薬物治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：標的治療、化学治療、免疫治療
がん薬物治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫治療（IL-2）
がん薬物治療の用途別グローバル売上・予測

・地域別市場分析
地域別がん薬物治療市場規模 2022年と2029年
地域別がん薬物治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labs
...

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report aims to provide a comprehensive presentation of the global market for Cancer Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Drug Therapy. This report contains market size and forecasts of Cancer Drug Therapy in global, including the following market information:
Global Cancer Drug Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Drug Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Drug Therapy companies in 2022 (%)
The global Cancer Drug Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Drug Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Type, 2022 (%)
Targeted Therapy
Chemotherapy
Immunotherapy
Global Cancer Drug Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Application, 2022 (%)
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Global Cancer Drug Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Drug Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Drug Therapy revenues share in global market, 2022 (%)
Key companies Cancer Drug Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Drug Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Drug Therapy, market overview.
Chapter 2: Global Cancer Drug Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Drug Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Drug Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Drug Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Cancer Drug Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Drug Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Drug Therapy Overall Market Size
2.1 Global Cancer Drug Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Drug Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Drug Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Drug Therapy Players in Global Market
3.2 Top Global Cancer Drug Therapy Companies Ranked by Revenue
3.3 Global Cancer Drug Therapy Revenue by Companies
3.4 Global Cancer Drug Therapy Sales by Companies
3.5 Global Cancer Drug Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Drug Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Drug Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Drug Therapy Players in Global Market
3.8.1 List of Global Tier 1 Cancer Drug Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Drug Therapy Market Size Markets, 2022 & 2029
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.2 By Type – Global Cancer Drug Therapy Revenue & Forecasts
4.2.1 By Type – Global Cancer Drug Therapy Revenue, 2018-2023
4.2.2 By Type – Global Cancer Drug Therapy Revenue, 2024-2029
4.2.3 By Type – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
4.3 By Type – Global Cancer Drug Therapy Sales & Forecasts
4.3.1 By Type – Global Cancer Drug Therapy Sales, 2018-2023
4.3.2 By Type – Global Cancer Drug Therapy Sales, 2024-2029
4.3.3 By Type – Global Cancer Drug Therapy Sales Market Share, 2018-2029
4.4 By Type – Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Drug Therapy Market Size, 2022 & 2029
5.1.2 Angiogenesis Inhibitors
5.1.3 mTOR Inhibitors
5.1.4 Monoclonal Antibodies
5.1.5 Cytokine Immunotherapy (IL-2)
5.2 By Application – Global Cancer Drug Therapy Revenue & Forecasts
5.2.1 By Application – Global Cancer Drug Therapy Revenue, 2018-2023
5.2.2 By Application – Global Cancer Drug Therapy Revenue, 2024-2029
5.2.3 By Application – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
5.3 By Application – Global Cancer Drug Therapy Sales & Forecasts
5.3.1 By Application – Global Cancer Drug Therapy Sales, 2018-2023
5.3.2 By Application – Global Cancer Drug Therapy Sales, 2024-2029
5.3.3 By Application – Global Cancer Drug Therapy Sales Market Share, 2018-2029
5.4 By Application – Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Drug Therapy Market Size, 2022 & 2029
6.2 By Region – Global Cancer Drug Therapy Revenue & Forecasts
6.2.1 By Region – Global Cancer Drug Therapy Revenue, 2018-2023
6.2.2 By Region – Global Cancer Drug Therapy Revenue, 2024-2029
6.2.3 By Region – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
6.3 By Region – Global Cancer Drug Therapy Sales & Forecasts
6.3.1 By Region – Global Cancer Drug Therapy Sales, 2018-2023
6.3.2 By Region – Global Cancer Drug Therapy Sales, 2024-2029
6.3.3 By Region – Global Cancer Drug Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cancer Drug Therapy Revenue, 2018-2029
6.4.2 By Country – North America Cancer Drug Therapy Sales, 2018-2029
6.4.3 US Cancer Drug Therapy Market Size, 2018-2029
6.4.4 Canada Cancer Drug Therapy Market Size, 2018-2029
6.4.5 Mexico Cancer Drug Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cancer Drug Therapy Revenue, 2018-2029
6.5.2 By Country – Europe Cancer Drug Therapy Sales, 2018-2029
6.5.3 Germany Cancer Drug Therapy Market Size, 2018-2029
6.5.4 France Cancer Drug Therapy Market Size, 2018-2029
6.5.5 U.K. Cancer Drug Therapy Market Size, 2018-2029
6.5.6 Italy Cancer Drug Therapy Market Size, 2018-2029
6.5.7 Russia Cancer Drug Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Drug Therapy Market Size, 2018-2029
6.5.9 Benelux Cancer Drug Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cancer Drug Therapy Revenue, 2018-2029
6.6.2 By Region – Asia Cancer Drug Therapy Sales, 2018-2029
6.6.3 China Cancer Drug Therapy Market Size, 2018-2029
6.6.4 Japan Cancer Drug Therapy Market Size, 2018-2029
6.6.5 South Korea Cancer Drug Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Drug Therapy Market Size, 2018-2029
6.6.7 India Cancer Drug Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cancer Drug Therapy Revenue, 2018-2029
6.7.2 By Country – South America Cancer Drug Therapy Sales, 2018-2029
6.7.3 Brazil Cancer Drug Therapy Market Size, 2018-2029
6.7.4 Argentina Cancer Drug Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cancer Drug Therapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cancer Drug Therapy Sales, 2018-2029
6.8.3 Turkey Cancer Drug Therapy Market Size, 2018-2029
6.8.4 Israel Cancer Drug Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Drug Therapy Market Size, 2018-2029
6.8.6 UAE Cancer Drug Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Company Summary
7.1.2 Amgen / Allergan Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Major Product Offerings
7.1.4 Amgen / Allergan Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Amgen / Allergan Key News & Latest Developments
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Company Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Major Product Offerings
7.2.4 Argos Therapeutics Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Argos Therapeutics Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Major Product Offerings
7.3.4 AstraZeneca Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Company Summary
7.4.2 Aveo Pharmaceuticals Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Major Product Offerings
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Aveo Pharmaceuticals Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cancer Drug Therapy Major Product Offerings
7.5.4 Bayer Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Exelixis
7.6.1 Exelixis Company Summary
7.6.2 Exelixis Business Overview
7.6.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.6.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Exelixis Key News & Latest Developments
7.7 Incyte
7.7.1 Incyte Company Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Cancer Drug Therapy Major Product Offerings
7.7.4 Incyte Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Incyte Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Cancer Drug Therapy Major Product Offerings
7.8.4 Merck Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Cancer Drug Therapy Major Product Offerings
7.9.4 Roche Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Major Product Offerings
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
7.11 Eisai
7.11.1 Eisai Company Summary
7.11.2 Eisai Cancer Drug Therapy Business Overview
7.11.3 Eisai Cancer Drug Therapy Major Product Offerings
7.11.4 Eisai Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Eisai Key News & Latest Developments
7.12 Exelixis
7.12.1 Exelixis Company Summary
7.12.2 Exelixis Cancer Drug Therapy Business Overview
7.12.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.12.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Exelixis Key News & Latest Developments
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Company Summary
7.13.2 Genentech (Roche) Cancer Drug Therapy Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Major Product Offerings
7.13.4 Genentech (Roche) Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Genentech (Roche) Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Cancer Drug Therapy Major Product Offerings
7.14.4 Novartis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.14.5 Novartis Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Cancer Drug Therapy Major Product Offerings
7.15.4 Pfizer Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Pfizer Key News & Latest Developments
7.16 Prometheus Labs
7.16.1 Prometheus Labs Company Summary
7.16.2 Prometheus Labs Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Major Product Offerings
7.16.4 Prometheus Labs Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.16.5 Prometheus Labs Key News & Latest Developments
8 Global Cancer Drug Therapy Production Capacity, Analysis
8.1 Global Cancer Drug Therapy Production Capacity, 2018-2029
8.2 Cancer Drug Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Drug Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Drug Therapy Supply Chain Analysis
10.1 Cancer Drug Therapy Industry Value Chain
10.2 Cancer Drug Therapy Upstream Market
10.3 Cancer Drug Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Drug Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 乳がん標的療法のグローバル市場展望 2023年-2029年：ブランド医薬品、ジェネリック医薬品
  • CAR-T細胞治療薬のグローバル市場展望 2023年-2029年：CD19標的、BCMA標的
  • 抗がん剤曝露評価サービスのグローバル市場展望 2023年-2029年：がん標的治療薬、免疫療法薬、その他
  • 万能細胞治療薬のグローバル市場展望 2023年-2029年：細胞治療、遺伝子治療、幹細胞治療
  • 注射ペプチド医薬品のグローバル市場展望 2023年-2029年：静脈注射、皮下注射
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8387 )"がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療" (英文：Cancer Drug Therapy Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。